Literature DB >> 2598956

Assessment of the binding properties of Granuloszint.

P A Schubiger1, P H Hasler, I Novak-Hofer, P Bläuenstein.   

Abstract

123I-Granuloszint (a murine monoclonal antibody--called AK-47--against NCA-95 glycoprotein of granulocytes) has been proved to be a very convenient and successful radiopharmaceutical for visualizing infectious diseases. For a broad introduction in routine nuclear medicine it was necessary to optimize the labelling method and to determine in vitro exactly those biological and binding parameters which are relevant for an effective application in vivo. Binding to granulocytes has been shown to be specific and saturable (non specific binding about 10%) and is not via the Fc part of the antibody. The investigation of the binding properties of 125I-labelled AK-47 gave the following results: affinity constant 5 x 10(8) M-1, 20,000-200,000 epitopes per granulocyte and an immunoreactivity of more than 90%. Labelling with 123I reduced the immunoreactivity to 40%. The Lindmo method and immunoblotting are used as quality control to check the likely in vivo behaviour of the labelled antibody. There is a good correspondence between the results from the two methods. With our special labelling method and the different in vitro tests we have found a reliable way to control the production and to assure an optimal binding behaviour of 123I-Granuloszint.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2598956     DOI: 10.1007/bf00256938

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

1.  Immunoscintigraphic localization of inflammatory lesions: concept, radiolabelling and in vitro testing of a granulocyte specific antibody.

Authors:  R Y Andres; P A Schubiger; L Tiefenauer; K Seybold; J T Locher; J P Mach; F Buchegger
Journal:  Eur J Nucl Med       Date:  1988

2.  Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.

Authors:  T Lindmo; E Boven; F Cuttitta; J Fedorko; P A Bunn
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

3.  Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD.

Authors:  F Buchegger; M Schreyer; S Carrel; J P Mach
Journal:  Int J Cancer       Date:  1984-05-15       Impact factor: 7.396

4.  Immunoscintigraphic localization of inflammatory lesions: pharmacokinetics and estimated absorbed radiation dose in man.

Authors:  P H Hasler; K Seybold; R Y Andres; J T Locher; P A Schubiger
Journal:  Eur J Nucl Med       Date:  1988

5.  Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal anti-granulocytes antibodies.

Authors:  J T Locher; K Seybold; R Y Andres; P A Schubiger; J P Mach; F Buchegger
Journal:  Nucl Med Commun       Date:  1986-09       Impact factor: 1.690

6.  Immunoscintigraphic localization of inflammatory lesions: clinical experience.

Authors:  K Seybold; J T Locher; C Coosemans; R Y Andres; P A Schubiger; P Bläuenstein
Journal:  Eur J Nucl Med       Date:  1988
  6 in total
  3 in total

1.  A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy.

Authors:  Inga Buchmann; Thomas Kull; Gerhard Glatting; Donald Bunjes; Geoffrey Hale; Jorg Kotzerke; Dirk Rattat; Hartmut Dohner; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-22       Impact factor: 9.236

2.  Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia.

Authors:  Christian Koenecke; Michael Hofmann; Oliver Bolte; Peter Gielow; Elke Dammann; Michael Stadler; Anke Franzke; Anne Rose Boerner; Matthias Eder; Arnold Ganser; Wolfram Knapp; Bernd Hertenstein
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

3.  Experience with the iodine-123 and technetium-99m labelled anti-granulocyte antibody MAb47: a comparison of labelling methods.

Authors:  P Bläuenstein; J T Locher; K Seybold; H Koprivova; G A Janoki; H R Mäcke; P Hasler; A Ammann; I Novak-Hofer; A Smith
Journal:  Eur J Nucl Med       Date:  1995-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.